Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Showing 20 of 0 results

Not applicableUnknownNCT05601518
What this trial is testing

Efficacy and Safety of Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir Tablets for the Treatment of Chronic HCV Infection: A Prospective, Multi-center Real-world Study.

Who this might be right for
Hepatitis C Infection
Beijing Tsinghua Chang Gung Hospital 450
Large-scale testing (Phase 3)Ended earlyNCT01446250
What this trial is testing

Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C
Debiopharm International SA 8
Not applicableStudy completedNCT04271865
What this trial is testing

Dates a Food Treasure in Alleviating Anemia

Who this might be right for
Anemia, Iron Deficiency
National Research Centre, Egypt 131
Not applicableStudy completedNCT03654365
What this trial is testing

Advanced Electronic Population Health and Personal Health Record Tools to Improve Once Lifetime Hepatitis C Screening

Who this might be right for
Hepatitis C
MetroHealth Medical Center 1,024
Early research (Phase 1)Study completedNCT02076100
What this trial is testing

Safety, Pharmacokinetics, and Pharmacodynamics of Ruzasvir (MK-8408) in Participants With Hepatitis C Infection (MK-8408-003)

Who this might be right for
Hepatitis C Infection
Merck Sharp & Dohme LLC 22
Not applicableWithdrawnNCT00976781
What this trial is testing

Identifying the Gaps in the Diagnosis and Management of Hepatitis C

Who this might be right for
Hepatitis C
Henry Ford Health System
Early research (Phase 1)Study completedNCT01090700
What this trial is testing

TMC435-TiDP16-C112 - Interaction Trial With Antidepressants

Who this might be right for
Hepatitis C Virus
Tibotec Pharmaceuticals, Ireland 20
Large-scale testing (Phase 3)Study completedNCT02705534
What this trial is testing

Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1

Who this might be right for
Hepatitis CCirrhosis
Tehran University of Medical Sciences 50
Not applicableWithdrawnNCT02070107
What this trial is testing

Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection

Who this might be right for
Hepatitis C
University of Louisville
Not applicableStudy completedNCT00794911
What this trial is testing

Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation

Who this might be right for
Chronic HCV
Beth Israel Deaconess Medical Center 75
Not applicableStudy completedNCT01508130
What this trial is testing

An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 672
Early research (Phase 1)Study completedNCT01537900
What this trial is testing

A Multiple Dose Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Participants (MK-5172-010)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 4
Testing effectiveness (Phase 2)Study completedNCT01185028
What this trial is testing

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Who this might be right for
Hepatitis C InfectionHIV Infection
National Institutes of Health Clinical Center (CC) 8
Not applicableStudy completedNCT00723892
What this trial is testing

Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)

Who this might be right for
Hepatitis C, ChronicHepacivirus
Merck Sharp & Dohme LLC 614
Not applicableUnknownNCT01760148
What this trial is testing

Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)

Who this might be right for
Hepatitis C, ChronicLiver DiseasesInterferon Deficiency
Junqi Niu 300
Not applicableStudy completedNCT04204447
What this trial is testing

Hepatitis C-Video vs. Brochure Education Delivery

Who this might be right for
Hepatitis C
State University of New York at Buffalo 176
Not applicableLooking for participantsNCT05713136
What this trial is testing

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

Who this might be right for
Hepatitis C
Kirby Institute 40,000
Not applicableStudy completedNCT01112033
What this trial is testing

Biliverdin Reductase A in Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Charles University, Czech Republic 113
Testing effectiveness (Phase 2)Study completedNCT00911963
What this trial is testing

Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 49
Testing effectiveness (Phase 2)Study completedNCT00062816
What this trial is testing

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

Who this might be right for
Hepatitis C, Chronic
Ionis Pharmaceuticals, Inc. 22
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation